Neurostimulators are becoming increasingly prevalent in the treatment of a number of serious medical conditions, including Parkinson’s disease, epilepsy, depression and chronic pain. As market opportunities expand, companies are seeking ways to differentiate themselves and increase their clinical reach. This audio conference presentation provides an overview of both current and developmental neuorstimulation devices, and discusses the commercial and clinical significance of these therapies.

Our speaker examines how neurostimulation may affect the clinical management of nervous system disorders in the future, and provides strategic insight into the commercial relevance of these therapies. The presentation also discusses similarities and differences between the various devices, as well as potential opportunities within the neurological stimulator market.

This audio conference covers:

• Scientific and clinical overview
• Commercial portfolio insights
• Device comparisons
• Key issues for consideration in the device markets

About the speaker:

Jessica Swartz, Ph.D. is a consultant at IMS Consulting Group. Her background includes research examining the effects of neurological stimulation and injury on motor function, mood disorders and homeostatic regulation. She has a master's degree in psychology and a Ph.D. in neuroscience. After receiving her degree for studying the effects of peripheral nerve injury and activity blockade on CNS plasticity and processing, Jessica joined IMS, where she specializes in product and portfolio strategy. Her expertise is in CNS disorders and pain, with a primary focus on identifying key challenges and opportunities in these fields.

Who should attend?

• Clinical
• R&D/Engineering
• Sales
• Marketing
• Business Development